Prospective Assessment of Procedure-Related and Patient-Reported Outcomes After Retrograde Intrarenal Surgery (RIRS) for Renal Calculi Less Than 20 mm

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT03719456
Collaborator
(none)
340
2
1
49
170
3.5

Study Details

Study Description

Brief Summary

The investigators aim at this study to prospectively assess procedure-related outcomes after RIRS for renal calculi less than 20 mm, including stone free rate (SFR), predictors of successful outcome, complications types/rate, readmission rate and the need of auxiliary procedures. In addition, patient-reported outcomes after this modality of intervention are going to be assessed.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Retrograde Intrarenal Surgery
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
340 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Prospective Assessment of Procedure-Related and Patient-Reported Outcomes After Retrograde Intrarenal Surgery (RIRS) for Renal Calculi Less Than 20 mm
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Feb 1, 2021
Actual Study Completion Date :
Feb 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Flexible ureteroscope

Procedure: Retrograde Intrarenal Surgery
Other Names:
  • Flexible ureteroscope
  • Outcome Measures

    Primary Outcome Measures

    1. stone free rate (SFR) [It will be assessed by non contrast computed tomography for the participants one month after the procedure]

      stone free rate after the procedure

    Secondary Outcome Measures

    1. Predictors of operative time of the procedure [Immediately after the procedure]

      Predictors of operative time of the procedure

    2. - Post-operative complications using modified Dindo-Clavian grading system [within 30 days after the procedure]

      - Post-operative complications (Type/rate/predictors) using modified Dindo-Clavian grading system

    3. Intra-operative clinical judgment of the surgeon on stone free status using flouroscopy and visual scanning of pelvicalyceal system and its relation to post-operative NCCT. [Post operative day 1 after the procedure]

      - Intra-operative surgeon perspective about procedure outcome and its relation to post-operative NCCT.

    4. - Patient -reported outcomes about post operative pain using visual analogue scale [within 3 months after the procedure]

      • Post-operative pain: Postoperative pain will be evaluated in all patients by using visual analogue scale (VAS). The impact of patient-related, stone-related and procedure-related factors.

    5. Patient -reported outcomes about General impression on the procedure using Freiburg Index of patient Satisfaction (FIPS). [within 3 months after the procedure]

      Patient -reported outcomes about General impression on the procedure using Freiburg Index of patient Satisfaction (FIPS).

    6. Assessment of patient-reported outcomes using patient-reported outcomes measurements information system (PROMIS) [within 3 months after the procedure]

      Procedure impact on improvement in patient-reported outcomes measurements information system (PROMIS): PROMIS is a National Institute of Health (NIH) validated system to assess patient quality of life. The PROMIS survey consists of 43 questions assessing the following categories: anxiety/fear, depression/ sadness, fatigue, pain interference, physical function, and sleep disturbance.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Ability to give informed consent.

    2. Stone criteria:

    • Less than 20 mm.

    • Infectious stone.

    • Growing stone on follow-up.

    1. Kidney criteria:
    • Obstructing stone causing hydronephrosis.

    • Solitary kidney or bilateral renal stones.

    1. Patients criteria:
    • Age ≥18 years.

    • Symptomatic stone causing pain or hematuria.

    • Patient comorbidity omitting other modalities as bleeding diathesis or skeletal deformities.

    • Patient preference or patients' social situation concerning profession or amount of travel

    Exclusion Criteria:
    1. Inability to give informed consent.

    2. Stone criteria:

    • More than 20 mm.

    • Peripheral calyceal asymptomatic stone static in size on follow-up.

    • Unsuitable/failure of initial treatment modalities (oral dissolution therapy-SWL) for stones less than 20 mm.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Urology and Nephrology Center Mansourah DK Egypt 35516
    2 Amr A Elsawy Al Manşūrah Egypt 35516

    Sponsors and Collaborators

    • Mansoura University

    Investigators

    • Principal Investigator: Amr A Elsawy, MD, Urology and Nephrology Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Amr Abdel-Lateif El-Sawy, Principal Investigator, Mansoura University
    ClinicalTrials.gov Identifier:
    NCT03719456
    Other Study ID Numbers:
    • AE 2394
    First Posted:
    Oct 25, 2018
    Last Update Posted:
    Nov 23, 2021
    Last Verified:
    Nov 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Amr Abdel-Lateif El-Sawy, Principal Investigator, Mansoura University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 23, 2021